Publications
- Anti-EGFR treatment of colorectal cancer2021 | Publication without faculty affiliation
- Panitumumab in the treatment of colorectal carcinoma2020 | Publication without faculty affiliation
- Panitumumab as first-line treatment of colorectal cancer2019 | Publication without faculty affiliation
- Efficacy and Toxicity of Panitumumab After Progression on Cetuximab and Predictive Value of MiR-31-5p in Metastatic Wild-type KRAS Colorectal Cancer Patients2016 | Central Library of Charles University, First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Recent advances in immunotherapy for metastatic colorectal cancer2023 | Publication without faculty affiliation
- The role of vaccines in the prevention and treatment of head and neck cancer2022 | Publication without faculty affiliation
- PD-1 inhibitors in the treatment of advanced esophageal cancer2021 | Publication without faculty affiliation
- Panitumumab in the first-line treatment of elderly patients - results of the PANDA study2021 | Publication without faculty affiliation
- Identifying predictors of response to unresectable hepatocellular carcinoma treatment with checkpoint inhibitors remains a challenge for the future2021 | Publication without faculty affiliation
- High microsatellite instability in gastric cancer is an important biomarker of sensitivity to immunotherapy2021 | Publication without faculty affiliation
Loading network view...